74 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB bought a new stake in Mettler-Toledo International Inc. (NYSE:MTD) during the third quarter, Holdings Channel.com reports. The firm bought 74 shares of the medical instruments supplier’s stock, valued at approximately $111,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MTD. International Assets Investment Management LLC boosted its holdings in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after acquiring an additional 89,922 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after purchasing an additional 35,048 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Mettler-Toledo International by 17.5% during the third quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock valued at $266,891,000 after purchasing an additional 26,443 shares in the last quarter. Barclays PLC grew its holdings in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in shares of Mettler-Toledo International by 1,940.6% in the third quarter. Thrivent Financial for Lutherans now owns 18,406 shares of the medical instruments supplier’s stock valued at $27,604,000 after buying an additional 17,504 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,206.02 on Friday. The company has a market cap of $25.45 billion, a P/E ratio of 32.52, a PEG ratio of 4.19 and a beta of 1.13. Mettler-Toledo International Inc. has a fifty-two week low of $1,115.64 and a fifty-two week high of $1,546.93. The stock has a 50 day simple moving average of $1,288.23 and a two-hundred day simple moving average of $1,372.15.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Activity

In other news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on MTD shares. Robert W. Baird cut their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Evercore ISI raised their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Wolfe Research started coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,351.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.